Company news
Pyxis Oncology, Inc. news in 2022
Pyxis Oncology, Inc.'s news releases, calls and decks from 2022, newest first.
Pyxis Oncology Announces FDA Clearance of Two IND Applications
November 30, 2022
Pyxis Oncology Reports Financial Results for the Quarter Ended September 30, 2022 and Provides Corporate Update
October 31, 2022
Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update
August 14, 2022
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference
June 27, 2022
Pyxis Oncology Announces Presentations at Upcoming Investor Conferences
May 18, 2022
Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update
May 12, 2022
Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference
April 26, 2022
Pyxis Oncology Announces Leadership Changes
April 12, 2022
Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T (PYX-106) Presented by Biosion, Inc. at the 2022 American Association for Cancer Research (AACR) Annual Meeting
April 7, 2022
Pyxis Oncology Provides Corporate and Financial Update
March 28, 2022
Biosion licenses BSI-060T (anti-Siglec-15) to Pyxis Oncology
March 28, 2022
Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022
March 21, 2022
Decks in 2022
- Society for Immunotherapy of Cancer (SITC) Annual Meeting 2022
Conference · 25 slides · Nov 10, 2022
- ASCO 2022
Conference · 14 slides · June 2022
- Technical Presentation (April 2022)
Technical · 21 slides · April 2022